Home
About
Overview
Sharing Data
ORCID
Help
History (8)
Institutional Practice
Multiple Carboxylase Deficiency
In vivo function and membrane binding properties are correlated for Escherichia coli lamB signal peptides.
Reducing analytical variation between point-of-care and laboratory HbA1c testing.
HMG CoA reductase inhibitors (statins): use in stroke prevention and outcome after stroke.
See All 8 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
HMG CoA reductase inhibitors (statins): use in stroke prevention and outcome after stroke.
Moonis M, Fisher M. HMG CoA reductase inhibitors (statins): use in stroke prevention and outcome after stroke. Expert Rev Neurother. 2004 Mar; 4(2):241-7.
View in:
PubMed
subject areas
Animals
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Randomized Controlled Trials as Topic
Stroke
Treatment Outcome
authors with profiles
Majaz Moonis MD